Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection
Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. Difficile Infection
Sponsor: Vancouver Island Health Authority
Listed as NCT03834038, this NA trial focuses on Recurrent Clostridium Difficile Infection and remains completed. Sponsored by Vancouver Island Health Authority, it has been updated 7 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Oct 2024 — Present [monthly]
Completed NA
Status: Unknown → Completed
-
Sep 2024 — Oct 2024 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
▶ Show 2 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2019 — Jun 2019 [monthly]
Active Not Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Vancouver Island Health Authority
For direct contact, visit the study record on ClinicalTrials.gov .